Solasia Pharma K.K. (4597.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In JPY
| Market Cap | 6.89B |
| Enterprise Value | 5.66B |
| P/E Ratio | -6.52 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 15.31 |
| Price/Book Ratio | 3.61 |
| Enterprise/Revenue | 11.7 |
| Enterprise/EBITDA | -5.77 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -2.17 |
| Operating Margin | -2.12 |
| Return On Assets | -0.45 |
| Return On Equity | -0.55 |
| Revenue | 429M |
| Revenue/Share | 1.53 |
| Gross Profit | 171M |
| EBITDA | -822M |
| Net Income | -876M |
| Diluted EPS | -3.69 |
| Total Cash | 1.57B |
| Total Cash/Share | 5.85 |
| Total Debt | 86M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 8.02 |
| Book Value Per Share | 6.38 |
| 52-Week Change | -25.81 |
| 52-Week High | 48 |
| 52-Week Low | 21 |
| Moving Average 50 Days | 28.82 |
| Moving Average 200 Days | 31.48 |
| Average Volume | 63.04M |
| Shares Outstanding | 273.01M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |